Last reviewed · How we verify
High Morphine Dose
At a glance
| Generic name | High Morphine Dose |
|---|---|
| Also known as | High Dose |
| Sponsor | Yale University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- COVID-19
- Headache
- Nasopharyngitis
- Urinary tract infection
- Nausea
- Vomiting
- Anemia
- Diarrhea
- Fever
- Hypertension
- Platelet count decreased
- Sinus tachycardia
Key clinical trials
- Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative Pain (PHASE2)
- A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS) (PHASE3)
- Next Generation Personalized Neuroblastoma Therapy (PHASE1)
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers (PHASE1, PHASE2)
- An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis (PHASE1, PHASE2)
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) (PHASE3)
- Anrikefon-based Patient-controlled Intravenous Analgesia After Laparoscopic Surgery (PHASE4)
- Spinal Anesthesia For Enhanced Recovery After Liver Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |